Tiziana Life Sciences Ltd Statistics
Share Statistics
Tiziana Life Sciences Ltd has 111.46M
shares outstanding. The number of shares has increased by 7.34%
in one year.
| Shares Outstanding | 111.46M |
| Shares Change (YoY) | 7.34% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,877 |
| FTD / Avg. Volume | 0.26% |
Short Selling Information
The latest short interest is 957.04K, so 0.82% of the outstanding
shares have been sold short.
| Short Interest | 957.04K |
| Short % of Shares Out | 0.82% |
| Short % of Float | 1.23% |
| Short Ratio (days to cover) | 2.44 |
Valuation Ratios
The PE ratio is -3.21 and the forward
PE ratio is null.
Tiziana Life Sciences Ltd's PEG ratio is
-0.24.
| PE Ratio | -3.21 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 10.27 |
| P/FCF Ratio | -3.62 |
| PEG Ratio | -0.24 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Tiziana Life Sciences Ltd.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12,
with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.12 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.02 |
| Interest Coverage | -1798.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,965,666.67 |
| Employee Count | 9 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 449K |
| Effective Tax Rate | -2.6% |
Stock Price Statistics
The stock price has increased by 82.26% in the
last 52 weeks. The beta is 0.13, so Tiziana Life Sciences Ltd's
price volatility has been higher than the market average.
| Beta | 0.13 |
| 52-Week Price Change | 82.26% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 50.92 |
| Average Volume (20 Days) | 731,651 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.98M |
| Net Income | -17.69M |
| EBITDA | -17.14M |
| EBIT | -17.23M |
| Earnings Per Share (EPS) | -0.17 |
Full Income StatementBalance Sheet
The company has 1.18M in cash and 247K in
debt, giving a net cash position of 936K.
| Cash & Cash Equivalents | 1.18M |
| Total Debt | 247K |
| Net Cash | 936K |
| Retained Earnings | -133.68M |
| Total Assets | 12.18M |
| Working Capital | 798K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -15.7M
and capital expenditures 0, giving a free cash flow of -15.7M.
| Operating Cash Flow | -15.7M |
| Capital Expenditures | n/a |
| Free Cash Flow | -15.7M |
| FCF Per Share | -0.15 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
